fpl-52694 has been researched along with remoxipride in 1 studies
| Studies (fpl-52694) | Trials (fpl-52694) | Recent Studies (post-2010) (fpl-52694) | Studies (remoxipride) | Trials (remoxipride) | Recent Studies (post-2010) (remoxipride) |
|---|---|---|---|---|---|
| 25 | 1 | 1 | 272 | 65 | 21 |
| Protein | Taxonomy | fpl-52694 (IC50) | remoxipride (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.4406 | |
| D(4) dopamine receptor | Homo sapiens (human) | 3.872 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for fpl-52694 and remoxipride
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |